跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
倍他乐克 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Metoprolol Succinate Sustained-release Tablets
Approved
化学药品
Metoprolol Succinate Sustained-release Tablets
ASTRAZENECA AB
🇨🇳 National Medical Products Administration
Approval Date
Dec 20, 2023
Approval ID
8XBioiFgm2t
Company
ASTRAZENECA AB
Type
化学药品
Approval Details
Approval Id
8XBioiFgm2t
Approval Number
国药准字HJ20140780
Generic Name
琥珀酸美托洛尔缓释片
Generic Name En
Metoprolol Succinate Sustained-release Tablets
Trade Name
倍他乐克
Drug Type
化学药品
Dosage Form
片剂
Strength
47.5mg
Reg Date
2023-12-20
Expired Date
2028-12-19
Company Name
ASTRAZENECA AB
Production Company Name
ASTRAZENECA AB
Company Detail Path
/organization/astrazeneca-ab
Production Company Detail Path
/organization/astrazeneca-ab
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 20, 2023
Approval ID
8XBioiFgm2t
Type
化学药品
Back to NMPA Approvals
